E-pharmacies in India — Regulatory landscape and challenges
Sarthak Sarin (Principal Associate) and Bharat Gupta (Associate), Khaitan & Co, give an insight on the need for better…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Number of IO trials in China surge by more than 50 per cent in 2016 and 2017
GlobalData identified 819 clinical trials that have been initiated in the last 10 years (2008-17) to investigate I/O drug…
Cipla agrees to buy South African pharma maker for INR 225 cr
Cipla said it has agreed to buy South African pharmaceuticals maker Mirren for 450 mln rand, or about INR 225 cr.
Drug regulator orders recall of Novartis’s painkiller diclofenac
Drug controller general of India (DCGI ) cancels licence for diclofenac sold by Novartis after concerns raised by a health…
Revisiting Ayush Policy
The government is trying to revive the AYUSH sector, but the success of its measures would rest on its ability to establish AYUSH…
DRL to appeal against US court decision
The US court barred DRL from sales and commercialisation of Buprenorphine and Naloxone Sublingual Film
Delhi hosts third edition of Healthcare Senate
Leaders and game changers in India’s private healthcare sector came together at the event organised by Express Healthcare and The…
Acing the value chain
It is ironical that a Chinese movie seems to have done what India's policy makers have been trying to do for many years: get China…